metyrapone has been researched along with Pancreatic Neoplasms in 5 studies
Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.
Pancreatic Neoplasms: Tumors or cancer of the PANCREAS. Depending on the types of ISLET CELLS present in the tumors, various hormones can be secreted: GLUCAGON from PANCREATIC ALPHA CELLS; INSULIN from PANCREATIC BETA CELLS; and SOMATOSTATIN from the SOMATOSTATIN-SECRETING CELLS. Most are malignant except the insulin-producing tumors (INSULINOMA).
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (60.00) | 18.7374 |
| 1990's | 1 (20.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kondo, T | 1 |
| Matsuyama, R | 1 |
| Ashihara, H | 1 |
| Matsuo, Y | 1 |
| Sasaki, K | 1 |
| Goto, R | 1 |
| Ono, K | 1 |
| Takaki, Y | 1 |
| Honda, Y | 1 |
| Iyama, K | 1 |
| Kawashima, J | 1 |
| Motoshima, H | 1 |
| Tsuruzoe, K | 1 |
| Miyamura, N | 1 |
| Araki, E | 1 |
| STAFFIERI, JJ | 1 |
| LENCIONI, LJ | 1 |
| EBERHARDT, DR | 1 |
| GORNI, DL | 1 |
| Soldan, M | 1 |
| Netter, KJ | 1 |
| Maser, E | 1 |
| Cagliero, E | 1 |
| Lorenzi, M | 1 |
| Upton, GV | 1 |
| Amatruda, TT | 1 |
5 other studies available for metyrapone and Pancreatic Neoplasms
| Article | Year |
|---|---|
A case of ectopic adrenocorticotropic hormone-producing pancreatic neuroendocrine tumor with multiple liver metastases.
Topics: Adrenocorticotropic Hormone; Chemoembolization, Therapeutic; Female; Hormones, Ectopic; Humans; Hydr | 2010 |
[HYPOGLYCEMIC SYNDROME DUE TO HYPERFUNCTIONING ISLET CELL ADENOMA].
Topics: Adenoma, Islet Cell; Clinical Laboratory Techniques; Glucose Tolerance Test; Humans; Hyperinsulinism | 1963 |
Induction of daunorubicin carbonyl reducing enzymes by daunorubicin in sensitive and resistant pancreas carcinoma cells.
Topics: Alcohol Oxidoreductases; Antineoplastic Agents; Benzaldehydes; Daunorubicin; Dose-Response Relations | 1996 |
The corticotropin-releasing factor test in the diagnosis of ectopic ACTH secretion.
Topics: ACTH Syndrome, Ectopic; Adenocarcinoma; Aged; Corticotropin-Releasing Hormone; Cushing Syndrome; Dex | 1987 |
Evidence for the presence of tumor peptides with corticotropin-releasing-factor-like activity in the ectopic ACTH syndrome.
Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Adrenocorticotropic Hormone; Amino Acids; Animals; Biolo | 1971 |